Table of Contents

October 2014, Volume 21, Number 5

Editorial

    • Laura Sterian Ward

    Thyroid tumors: are we unveiling the puzzle?

    Endocr Relat Cancer 21 (5) E7-E8, doi:10.1530/ERC-14-0407

Thematic Reviews

    • M A Marcello,
    • P Malandrino,
    • J F M Almeida,
    • M B Martins,
    • L L Cunha,
    • N E Bufalo,
    • G Pellegriti,
    • and L S Ward

    The influence of the environment on the development of thyroid tumors: a new appraisal

    Endocr Relat Cancer 21 (5) T235-T254, doi:10.1530/ERC-14-0131 first published on 19 June 2014
    • Marjory Alana Marcello,
    • Lucas Leite Cunha,
    • Fernando Assis Batista,
    • and Laura Sterian Ward

    Obesity and thyroid cancer

    Endocr Relat Cancer 21 (5) T255-T271, doi:10.1530/ERC-14-0070 first published on 16 April 2014
    • Michael Derwahl and
    • Diana Nicula

    Estrogen and its role in thyroid cancer

    Endocr Relat Cancer 21 (5) T273-T283, doi:10.1530/ERC-14-0053 first published on 22 July 2014
    • Zhenying Guo,
    • Heather Hardin,
    • and Ricardo V Lloyd

    Cancer stem-like cells and thyroid cancer

    Endocr Relat Cancer 21 (5) T285-T300, doi:10.1530/ERC-14-0002 first published on 30 April 2014
    • Susan J Hsiao and
    • Yuri E Nikiforov

    Molecular approaches to thyroid cancer diagnosis

    Endocr Relat Cancer 21 (5) T301-T313, doi:10.1530/ERC-14-0166 first published on 14 May 2014

Commentary

    • Paramita M Ghosh and
    • Allen C Gao

    Zoledronic acid at the time of castration prevented castration-induced bone metastasis in mice

    Endocr Relat Cancer 21 (5) C11-C14, doi:10.1530/ERC-14-0387 first published on 2 September 2014

Reviews

    • Jason Hatakeyama,
    • Jessica H Wald,
    • Ignat Printsev,
    • Hsin-Yi Henry Ho,
    • and Kermit L Carraway III

    Vangl1 and Vangl2: planar cell polarity components with a developing role in cancer

    Endocr Relat Cancer 21 (5) R345-R356, doi:10.1530/ERC-14-0141 first published on 30 June 2014
    • M Christine Bruce,
    • Danielle McAllister,
    • and Leigh C Murphy

    The kinome associated with estrogen receptor-positive status in human breast cancer

    Endocr Relat Cancer 21 (5) R357-R370, doi:10.1530/ERC-14-0232 first published on 23 July 2014
    • Ada S Cheung,
    • Jeffrey D Zajac,
    • and Mathis Grossmann

    Muscle and bone effects of androgen deprivation therapy: current and emerging therapies

    Endocr Relat Cancer 21 (5) R371-R394, doi:10.1530/ERC-14-0172 first published on 23 July 2014
    • Huy Q Ta and
    • Daniel Gioeli

    The convergence of DNA damage checkpoint pathways and androgen receptor signaling in prostate cancer

    Endocr Relat Cancer 21 (5) R395-R407, doi:10.1530/ERC-14-0217 first published on 5 August 2014
    • Claire E Fletcher,
    • D Alwyn Dart,
    • and Charlotte L Bevan

    Interplay between steroid signalling and microRNAs: implications for hormone-dependent cancers

    Endocr Relat Cancer 21 (5) R409-R429, doi:10.1530/ERC-14-0208 first published on 25 July 2014

Research

    • Amira Mohamed,
    • Marie-Pierre Blanchard,
    • Manuela Albertelli,
    • Federica Barbieri,
    • Thierry Brue,
    • Patricia Niccoli,
    • Jean-Robert Delpero,
    • Genevieve Monges,
    • Stephane Garcia,
    • Diego Ferone,
    • Tullio Florio,
    • Alain Enjalbert,
    • Vincent Moutardier,
    • Agnes Schonbrunn,
    • Corinne Gerard,
    • Anne Barlier,
    • and Alexandru Saveanu

    Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures

    Endocr Relat Cancer 21 (5) 691-704, doi:10.1530/ERC-14-0086 first published on 10 July 2014
    • Matthew H Kulke,
    • Thomas O'Dorisio,
    • Alexandria Phan,
    • Emily Bergsland,
    • Linda Law,
    • Phillip Banks,
    • Joel Freiman,
    • Kenny Frazier,
    • Jessica Jackson,
    • James C Yao,
    • Larry Kvols,
    • Pablo Lapuerta,
    • Brian Zambrowicz,
    • Douglas Fleming,
    • and Arthur Sands

    Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide

    Endocr Relat Cancer 21 (5) 705-714, doi:10.1530/ERC-14-0173 first published on 10 July 2014
    • Dong-Yeop Shin,
    • Soyeun Kim,
    • Sunhoo Park,
    • Jae Soo Koh,
    • Cheol Hyeon Kim,
    • HeeJong Baek,
    • Sung Hyun Yang,
    • and Im Il Na

    Serum 25-hydroxyvitamin D levels correlate with EGFR mutational status in pulmonary adenocarcinoma

    Endocr Relat Cancer 21 (5) 715-721, doi:10.1530/ERC-14-0259 first published on 16 July 2014
    • Varinder Jeet,
    • Gregor Tevz,
    • Melanie Lehman,
    • Brett Hollier,
    • and Colleen Nelson

    Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells

    Endocr Relat Cancer 21 (5) 723-737, doi:10.1530/ERC-14-0267 first published on 30 June 2014
    OPEN ACCESS ARTICLE
    • Paola De Marco,
    • Enrica Romeo,
    • Adele Vivacqua,
    • Roberta Malaguarnera,
    • Sergio Abonante,
    • Francesco Romeo,
    • Vincenzo Pezzi,
    • Antonino Belfiore,
    • and Marcello Maggiolini

    GPER1 is regulated by insulin in cancer cells and cancer-associated fibroblasts

    Endocr Relat Cancer 21 (5) 739-753, doi:10.1530/ERC-14-0245 first published on 10 July 2014
    • Devora Champa,
    • Marika A Russo,
    • Xiao-Hui Liao,
    • Samuel Refetoff,
    • Ronald A Ghossein,
    • and Antonio Di Cristofano

    Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression

    Endocr Relat Cancer 21 (5) 755-767, doi:10.1530/ERC-14-0268 first published on 10 July 2014
    • Penelope D Ottewell,
    • Ning Wang,
    • Joshua Meek,
    • C Anne Fowles,
    • Peter I Croucher,
    • Colby L Eaton,
    • and Ingunn Holen

    Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone

    Endocr Relat Cancer 21 (5) 769-781, doi:10.1530/ERC-14-0199 first published on 22 July 2014
    • Hongyu Chen,
    • Dan Liu,
    • Zhengyan Yang,
    • Limin Sun,
    • Que Deng,
    • Shuo Yang,
    • Lu Qian,
    • Liang Guo,
    • Ming Yu,
    • Meiru Hu,
    • Ming Shi,
    • and Ning Guo

    Adrenergic signaling promotes angiogenesis through endothelial cell–tumor cell crosstalk

    Endocr Relat Cancer 21 (5) 783-795, doi:10.1530/ERC-14-0236
    • Enke Baldini,
    • Chiara Tuccilli,
    • Natalie Prinzi,
    • Salvatore Sorrenti,
    • Alessandro Antonelli,
    • Lucio Gnessi,
    • Stefania Morrone,
    • Costanzo Moretti,
    • Marco Bononi,
    • Yannick Arlot-Bonnemains,
    • Massimino D'Armiento,
    • and Salvatore Ulisse

    Effects of selective inhibitors of Aurora kinases on anaplastic thyroid carcinoma cell lines

    Endocr Relat Cancer 21 (5) 797-811, doi:10.1530/ERC-14-0299 first published on 29 July 2014
    • V Fendrich,
    • C L Lopez,
    • J Manoharan,
    • K Maschuw,
    • S Wichmann,
    • A Baier,
    • J P Holler,
    • A Ramaswamy,
    • D K Bartsch,
    • and J Waldmann

    Enalapril and ASS inhibit tumor growth in a transgenic mouse model of islet cell tumors

    Endocr Relat Cancer 21 (5) 813-824, doi:10.1530/ERC-14-0175 first published on 13 August 2014
    • Rengyun Liu and
    • Mingzhao Xing

    Diagnostic and prognostic TERT promoter mutations in thyroid fine-needle aspiration biopsy

    Endocr Relat Cancer 21 (5) 825-830, doi:10.1530/ERC-14-0359 first published on 13 August 2014

Research Letter

    • Greta Gandolfi,
    • Dario de Biase,
    • Valentina Sancisi,
    • Moira Ragazzi,
    • Giorgia Acquaviva,
    • Annalisa Pession,
    • Simonetta Piana,
    • Giovanni Tallini,
    • and Alessia Ciarrocchi

    Deep sequencing of KIT, MET, PIK3CA, and PTEN hotspots in papillary thyroid carcinomas with distant metastases

    Endocr Relat Cancer 21 (5) L23-L26, doi:10.1530/ERC-14-0361 first published on 20 August 2014

Erratum

    • Marie McIlroy,
    • Fergal J Fleming,
    • Yvonne Buggy,
    • Arnold D K Hill,
    • and Leonie S Young

    Tamoxifen-induced ER–α–SRC3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence

    Endocr Relat Cancer 21 (5) X1-X3, doi:10.1677/erc.1.01222e
|

This Issue

October 2014; 21 (5)
  1. Editorial
  2. Thematic Reviews
  3. Commentary
  4. Reviews
  5. Research
  6. Research Letter
  7. Erratum

Find articles in this issue containing these words:

New Articles: issue in progress

  1. May 2016, 23 (5)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most